Description

2,4-Dichloro-2'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone is a high-value, advanced pharmaceutical intermediate featuring a complex molecular architecture. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated chemical scaffolds. It is primarily utilized by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in developing next-generation drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of complex drug molecules, especially those targeting central nervous system (CNS) disorders.
• Organic Synthesis Research: Serves as a versatile precursor for constructing spirocyclic and benzophenone-based compounds in medicinal chemistry.
• Protease Inhibitor Development: Potential use in the research and development of enzyme inhibitors due to its specific structural motifs.
• Chemical Biology Probes: Used in the design of molecular probes for studying biological pathways and protein interactions.
• Custom Synthesis Projects: Supplied to contract research organizations (CROs) and CDMOs for client-specific synthetic routes.
• Academic Research: Employed in university laboratories for methodological studies in heterocyclic and asymmetric synthesis.

Basic Information

Product Name	2,4-Dichloro-2'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone
CAS No.	898756-51-9
Molecular Formula	C21H21Cl2NO3
Molecular Weight	406.30 g/mol
Synonyms	2,4-Dichloro-2'-(8-(1,4-Dioxa-8-Azaspiro[4.5]Decan-8-yl)Methyl)Benzophenone; 2'-(8-(1,4-Dioxa-8-Azaspiro[4.5]Decan-8-yl)Methyl)-2,4-Dichlorobenzophenone; Benzophenone, 2,4-dichloro-2'-[8-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)methyl]-; 898756-51-9; CAS 898756-51-9; Spirocyclic Benzophenone Derivative; DDOAB
EINECS	Contact for details

Quality Control

Our production of 2,4-Dichloro-2'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone adheres to stringent quality protocols suitable for pharmaceutical R&D. Each batch undergoes comprehensive analytical characterization including HPLC, NMR, and mass spectrometry to confirm identity and purity. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to ensure traceability and batch-to-batch consistency for your critical research and development processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat and incompatible materials. The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.